3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
29
Lymphoma, Follicular
8
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma
7
Lymphoma, Non-Hodgkin
5
Leukemia, Lymphocytic, Chronic, B-Cell
4
Neoplasms
3
Smoldering Multiple Myeloma
2
Myelodysplastic Syndromes
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Burkitt Lymphoma
2
Recurrence
1
Neoplasms, Plasma Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
asciminib
2
venetoclax
1
gilteritinib
1
fludarabine phosphate
1
fludarabine
1
blinatumomab
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Idarubicin
1
Hyperbaric Oxygenation
1
Filgrastim
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Lenalidomide
×
30 days
×
Clear all
No trials found.